medigraphic.com
ISSN 1561-3046 (Electronic)

2014, Number 1

<< Back Next >>

Rev Cub Med Mil 2014; 43 (1)

Biodegradable stents in cardiology

Martínez GG, Sánchez TN, Suárez NA

Language: Spanish
References: 20
Page: 113-121
PDF size: 91.64 Kb.


ABSTRACT

Ischemic cardiopathy is the main cause of death in current Cuban society. Percutaneous transluminal coronary angioplasty with stent placement is no doubt one of the most promising therapeutic options. Stents have evolved in recent years in their structure and composition, from metallic to drug eluting. However, thrombosis is still a common and important complication that overshadows the success of the procedure and may lead patients to a new surgical intervention or even death, not to mention the economic cost. A bibliographic review was conducted about a novel stent model that promises to do away with the limitations of preceding models and introduces improvements which further the search for the ideal stent.


REFERENCES

  1. Murria CL, Lopez A. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349:1498-504.

  2. Mendis S, Puska P, Norrving B. Global Atlas on cardiovascular disease prevention and control. World Health Organization, Geneva, 2011. p. 1-54. [consultado diciembre 2011]. Disponible en: http://whqlibdoc.who.int/publications/2011/9789241564373_eng.pdf

  3. European Society of Hypertension-European Society of Cardiology. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. Hypertension. 2003;21(6):1011-53.

  4. Oficina Nacional de Estadísticas. Anuario Estadístico Nacional Cuba 2011. Edición 2012. Principales causas de muerte de todas las edades [consultado 11 Dic. 2012]. Disponible en: http://www.one.cu/aec2011/datos/19.17.xl

  5. Kaluza GL. Current status of polymeric biodegradable drug eluting stents: REVA Medical. J Interv Cardio 2006;19(2):124-7.

  6. Wykrzykowska JJ, Onuma Y, Serruys PW. Advances in stent drug delivery: the future is in bioabsorbable stents. Expert Opin Drug Deliv. 2009 Feb;6(2):113-26.

  7. Nakazawa G, Finn AV, Kolodgie FD, Virmani R. A review of current devices and a look at new technology: drug-eluting stents. Expert Rev Med Devices. 2009 Jan;6(1):33-42.

  8. William W, Pramod K, Kuchulakanti, Betty W, Leonardo C, William OS et al. Efficacy of Sirolimus-Eluting Stents as Compared to Paclitaxel-Eluting Stents for Saphenous Vein Graft Intervention. J Invasive Cardiol. 2006;18(2):70-4.

  9. Tamai H, Igaki K, Tsuji T. A biodegradable poly-L-lactic acid coronary stent in porcine coronary artery. J Interv Cardiol. 1999;12:443-50.

  10. Tamai H, Igaki K, Kyo E. Initial and 6-month results of biodegradable poly-L-lactic acid coronary stents in humans. Circulation. 2000;102:399-404.

  11. Grube E, Schofer J, Hauptmann KE, Nickenig G, Curzen N, Allocco DJ, Dawkins KD. A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcome with the JACTAX HD stent. JACC Cardiovasc Interv. 2010 Apr;3(4):431-8.

  12. Tsuji T, Tamai H, Igaki K. Biodegradable polymeric stents. Curr Interv Cardiol Rep. 2001;3:10-7.

  13. Garg S, Sarno G, Serruys PW, de Vries T, Buszman P. The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer. EuroIntervention. 2010 Jun;6(2):233-9.

  14. Tsuji T, Tamai H, Igaki K. One year follow-up of biodegradable self-expanding stent implantation in humans. J Am Coll Cardiol. 2001;37:A47.

  15. Heublein B, Rohde R, Kaese V. Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology? Heart. 2003;89:651-6.

  16. Hermawan H, Purnama A, Dube D, Couet J, Mantovani D. Fe-Mn alloys for metallic biodegradable stents: degradation and cell viability studies. Acta Biomater. 2010;6(5):1852-60.

  17. Granada JF, Inami S, Aboodi MS, Tellez A, Milewski K, Wallace-Bradley D, et al. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv. 2010 June;3(3):257-66.

  18. Ormiston JA. ABSORB first-in-man-day results. First reports session. J Invasive Cardiol. 2006;19(2):89-94.

  19. Lockwood NA, Hergenrother RW, Patrick LM, Stucke SM, Steendam R, Pacheco E, et al. In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings. J Biomater Sci Polym Ed. 2010; 21(4):529-52.

  20. Erbel, R. Biodegradable Heart Stent Shows Promise. Lancet. 2007 June;369:1869-75.




2020     |     www.medigraphic.com